MyChesCo on MSN3d
Virpax Pharmaceuticals to Present NES100 Toxicity Study at Major Toxicology ConferenceBERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced that findings from its dose range toxicity study for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback